Rational Substitution-Driven Enhancement of Anti- Mycobacterium tuberculosis Activity in a Quinoline–Isonicotinic Acid Hydrazide Hybrid
ACS Infectious Diseases · 14.08.2026 · 12 (8) · 2799-2814
DOI: 10.1021/acsinfecdis.6c00376 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 09.07.2026. Verfasst von Govinda Raju Vadankula und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pathogeneses, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad, Telangana500046,…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Quinolines, Isonicotinic Acids. Die Arbeit nennt 41 Literaturangaben. Gefördert von: University of Hyderabad, Department of Biotechnology , Ministry of Science and Technology, Department of Science and Technology, Ministry of Science and Technology.
Abstract (Originalsprache)
The obstinatproblem of drug resistance in tuberculosis (TB) requires sustained efforts in the search for new drug molecules. Building on our previously developed synthetic hybrid compound, UH-NIP-16, which demonstrated anti-Mycobacterium tuberculosis (M.tb) activity, we synthesized and evaluated 15 new derivatives to improve its potency. Among these, two lead compounds, UN-7 and UN-14, bearing hydrogen and methyl substitutions at the sixth position, respectively, along with a 2-phenoxy moiety, exhibited a ∼5-fold reduction in MIC50 values across laboratory, clinical, and multidrug-resistant M.tb strains relative to UH-NIP-16. Both compounds displayed a bacteriostatic mechanism of action and exhibited predominantly additive or indifferent interaction profiles in combinatorial antitubercular studies. Importantly, UN-7 and UN-14 showed minimal cytotoxicity toward mammalian cells and effectively reduced intracellular bacterial burden in an in vitro infection model. A coupled enzymatic assay revealed that UN-7 and UN-14 inhibited mycobacterial shikimate kinase (Mt-SK) activity by approximately 65%, a target not inhibited by the parent compound UH-NIP-16. In silico ADMET analyses indicated several favorable drug-likeness properties despite predicted liabilities, including Ames mutagenicity and low aqueous solubility. Collectively, these findings identify UN-7 and UN-14 as structure–activity relationship (SAR)-guided derivatives of the UH-NIP-16 scaffold with improved antimycobacterial activity and promising potential for further antitubercular lead development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Pathogeneses, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad, Telangana500046, India.
- Department of Medicinal Chemistry, National Institute of Pharmaceutical and Educational Research (NIPER), Hyderabad, Telangana500037, India.
- Division of Infectious Diseases & Vector Biology, ICMR-National Institute of Research in Tribal Health, Nagpur Road, Garha, Jabalpur, Madhya Pradesh482003, India.
ORCID-Profile: Govinda Raju Vadankula, Mohammed Arifuddin, Alvala Mallika, Sharmistha Banerjee
Förderung
- University of Hyderabad
- Department of Biotechnology , Ministry of Science and Technology
- Department of Science and Technology, Ministry of Science and Technology
Zitieren
APA
Vadankula, G. R., Agarwal, A., Sriram, Y., Saxena, S., Biswas, R., Chirra, H., Thacker, P. S., Arifuddin, M., Nema, V., Mallika, A., & Banerjee, S. (2026). Rational Substitution-Driven Enhancement of Anti- Mycobacterium tuberculosis Activity in a Quinoline–Isonicotinic Acid Hydrazide Hybrid. ACS Infectious Diseases, 12(8), 2799-2814. https://doi.org/10.1021/acsinfecdis.6c00376
Vancouver
Vadankula GR, Agarwal A, Sriram Y, Saxena S, Biswas R, Chirra H, et al. Rational Substitution-Driven Enhancement of Anti- Mycobacterium tuberculosis Activity in a Quinoline–Isonicotinic Acid Hydrazide Hybrid. ACS Infectious Diseases. 2026;12(8):2799-2814. doi:10.1021/acsinfecdis.6c00376
BibTeX
@article{Vadankula2026,
author = {Vadankula, Govinda Raju and Agarwal, Anushka and Sriram, Yandrapally and Saxena, Shalini and Biswas, Rashmita and Chirra, Hepsibha and Thacker, Pavitra S and Arifuddin, Mohammed and Nema, Vijay and Mallika, Alvala and Banerjee, Sharmistha},
title = {Rational Substitution-Driven Enhancement of Anti- Mycobacterium tuberculosis Activity in a Quinoline–Isonicotinic Acid Hydrazide Hybrid},
journal = {ACS Infectious Diseases},
year = {2026},
volume = {12},
number = {8},
pages = {2799--2814},
doi = {10.1021/acsinfecdis.6c00376}
}
EUVIMED